Non-alcoholic fatty liver disease fibrosis score is a useful tool for carotid atherosclerosis screening in patients with obstructive sleep apnea

Figure 4 Non-alcoholic fatty liver disease fibrosis score is related to carotid plaque presence and volume in patients with obstructive sleep apnea regardless of metabolic dysfunction-associated steatotic liver disease presence. All values are expressed as mean ± SD. A and B: Non-alcoholic fatty liver disease fibrosis score and fibrosis-4 scores in obstructive sleep apnea patients without metabolic dysfunction-associated steatotic liver disease according to carotid plaque absence (n = 6) or presence (n = 10); C and D: Spearman correlations for non-alcoholic fatty liver disease fibrosis score and fibrosis-4 scores and carotid plaque volume in obstructive sleep apnea patients without metabolic dysfunction-associated steatotic liver disease and carotid plaque presence (n = 10). NFS: Non-alcoholic fatty liver disease fibrosis score; FIB-4: Fibrosis-4.